Science
Science|HEADSTART-ACS
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology...
October 21, 2026 · 8:31 AM
Science
MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its LensAI™ immunogenicity screening ran across an entire public antibody database of 890,634 seque…
October 21, 2026 · 8:01 AM
Science|Global Network for the Advancement of Metabolic Psychiatry (MetPsy)
Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Clinical Care, Education and Research at McLean Hospital
MetPsy, a global network for metabolic psychiatry, launches with $20M Baszucki Group grant for new McLean Hospital clinical care and research center....
October 21, 2026 · 8:00 AM
Science|AI Proteins
AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced it has entered into a Research Collaboration and License Agreement with As…
October 21, 2026 · 8:00 AM
Science
IDWeek 2026: New Exploratory Analyses Evaluate XOCOVA® (ensitrelvir) Following COVID-19 Exposure, Including Breakthrough Infections and Infection Present at Baseline
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) will present new exploratory analyses from the global Phase 3 SCORPIO-PEP study, virology data from a…
October 21, 2026 · 8:00 AM Science
IDWeek 2026: Shionogi Presents U.S. Analysis of Real-World Data Showing Early Treatment Initiation with Fetroja®/Fetcroja® (cefiderocol) Improved Clinical Outcomes in Patients with Respiratory Infections
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) will present new data at IDWeek 2026 that reinforce the role of Fetroja®/Fetcroja® (cefiderocol), an…
October 21, 2026 · 8:00 AM
Science
Therna Biosciences Showcases RNA-Logix™, Its AI RNA Biologist Platform for Biological Discovery and Genomic Medicine Design
Therna Biosciences, a biotechnology company translating RNA language into genomic medicines, today showcased RNA-Logix™, its Recursive AI RNA Biologist platform. RNA-Logix brings together Therna’s RNA foundation models,…
October 21, 2026 · 7:30 AM
Science|Zai Lab to
Zai Lab to Announce Third Quarter 2026 Financial Results and Recent Corporate Updates on November 5, 2026
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its third quarter 2026 financial results and provide recent corporate updates on November 5, 2026, before the opening of U.S. equity markets.…
October 21, 2026 · 7:30 AM
Science
Foundation Medicine and Joint Collaborators to Present 12 Abstracts at the ESMO Congress 2026
Explore Foundation Medicine's 12 abstracts being presented at the ESMO Congress 2026....
October 21, 2026 · 7:00 AM
Science
AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced t…
October 21, 2026 · 7:00 AMLatest from leading organizations
Explore recent announcements by organization
